Kratom research: Areas, Discoveries, Implications, Obstacles, Policy, Public awareness, Community

The topic of Kratom research encompasses a broad spectrum of areas and methodologies. These efforts have unearthed a series of valuable discoveries, with far-reaching implications for various aspects of kratom. However, the journey of kratom research is not without its share of obstacles.

The methodologies adopted in kratom research are as diverse ranging from controlled laboratory experiments to large-scale surveys and clinical trials. These diverse Methodologies serve as the bedrock upon which reliable and credible findings are built.

Researchers have uncovered a wealth of insights, focusing particularly on kratom's alkaloids, such as Mitragynine and 7-hydroxymitragynine. These chemical constituents are pivotal in shaping the effects and potential applications of kratom.

The Implications of kratom research extend into several domains. Findings bear significance for understanding health effects, shaping regulatory policies, and exploring potential therapeutic benefits. Consequently, research outcomes have a tangible impact on public health and policy decisions.

Yet, kratom research grapples with notable Obstacles. Legal complexities surrounding kratom's status, insufficient funding, and gaps in data availability present formidable challenges. These hurdles often impede the progress of research endeavors.

The influence of kratom research extends beyond academia. It plays a pivotal role in shaping Policy, particularly in the context of drug scheduling and legalization decisions. Additionally, it contributes to raising Public Awareness by providing evidence-based information and combating misinformation through media coverage.

In this collaborative endeavor, the kratom Research Community thrives, bringing together experts from various fields, including interdisciplinary teams, academic institutions, and industry stakeholders. This collective effort strengthens the quality and breadth of research outcomes.

What is kratom research?

Kratom research revolves around the exploration and study of a tropical tree known as Mitragyna speciosa. This tree, native to Southeast Asia, is commonly referred to as 'kratom'. The leaves of this tree produce substances that have mind-altering (psychoactive) effects when consumed. Researchers focus on these substances, particularly the compounds called mitragynine and 7-hydroxymitragynine, which interact with opioid receptors in the brain to produce sedation, pleasure, and decrease pain.

While the potential therapeutic uses of kratom are a significant area of interest, studies also closely examine the possible adverse effects. Consumers have reported symptoms such as nausea, sweating, seizures, and psychotic symptoms after kratom usage. As it is increasingly marketed as an alternative to traditional opioid pain drugs, it's crucial to understand how these effects manifest and under which circumstances they can be harmful. Even though many see kratom as a potential refuge from the harmful effects of opioid drugs, the full picture of its safety and efficacy is far from resolved.

What is the focus areas of kratom research?

Mitragyna speciosa, commonly known as kratom, is under the microscopic lens of the scientific world for its potential use in different areas. Most notably, its use as dietary supplements and for the treatment of opioid withdrawal grabs significant attention. As part of this research, a review of regular kratom users has revealed interesting findings, such as potential therapeutic benefits for individuals dealing with the opioid epidemic. Mitragyna speciosa, due to its effect on the opioid receptors, appears to alleviate withdrawal symptoms from opioids, thereby presenting itself as a potential natural alternative.

Additionally, kratom research currently focuses heavily on chronic pain management. Many individuals have turned to kratom extracts as a supplement in their journey of mitigating chronic pain. This widespread use prompts researchers to undertake a rigorous investigation to determine the safety and effectiveness of kratom. In the face of the global opioid epidemic, which is often associated with chronic pain treatment, kratom's potential role in managing opioid use disorder symbolizes a beacon of hope. However, it’s crucial to underscore that while the therapeutic potential appears promising, substantial research remains necessary to fully explore and understand the many facets of kratom’s effects.

Which research methodologies are most commonly used to study kratom?

Delineating the potential methodologies employed to investigate kratom, recent years have observed a surge in clinical studies and systematic reviews. One prominent researcher in this discipline is Dr. Marc T. Swogger, whose work often incorporates comprehensive reviews of existing literature along with primary data collection. For example, Swogger’s research on user demographics of kratom involves collecting and analyzing data from regular users which gives qualitative insight into the consumption patterns, motivations, and health outcomes associated with kratom use.

Another common methodology is the utilization of data from poison control centers. This approach provides valuable real-world data on Adverse Events (AEs) associated with kratom use, which is key in medical treatment scenarios. A study by Post et al., used the National Poison Data System (NPDS) to identify single-substance kratom exposures reported to United States Poison Centers between 2011 and 2017. This study underlined the value of poison center data in forming an accurate picture of the risks associated with kratom use, particularly in those consuming kratom tea, a common method of ingestion. With these varied methodologies, kratom research continues to evolve, providing new insights and shaping public health strategies.

How do the implications of kratom research extend beyond the scientific community?

Kratom, a leafy plant endemic to Southeast Asia, is no stranger to the realm of illicit drugs—its notoriety as a psychoactive drug continues to spark significant debate across various domains. Furthermore, its underlying potential as a substitute for opioids has become a focal point within the context of substance use disorder. This phenomenon arises due to kratom's reported efficacy in reducing opioid withdrawal symptoms, a finding echoed by various scientific studies. Consequently, these investigations could influence drug abuse management strategies, especially considering the vast number of individuals who struggle with opioid dependency in the United States.

For instance, recent research conducted by Garcia-Romeu A and Smith KE has shed light on the plant's intriguing duality – it's potential for dependence, but also, might serve as an unconventional aid for those battling addiction. This compelling complexity has instigated further inquiry into its behavioral, pharmacological, and toxicological attributes. As Garcia-Romeu highlights, the understanding gleaned from such scientific interrogation carries considerable weight for health professionals, policymakers, and patients grappling with substance use disorders. Hence, kratom research may significantly impact tangible decisions and interventions beyond the scientific community.

What are some of the primary obstacles hindering progress in kratom research?

One of the salient challenges confounding kratom research is the lack of adequate controls. The Food and Drug Administration (FDA) has yet to establish a universally accepted standard towards the use and dosage of the psychoactive herbal drug, which consists principally of the alkaloids mitragynine. With heightened cases of Neonatal abstinence syndrome and kratom use disorder emanating from misuse, establishing standardized controls become even more imperative. The lack of controls not only stifles the research process but can also impede scientific clarity related to kratom's therapeutic potentials, thus limiting its implications for drug substitution therapy.

Furthermore, a surge in kratom exposures is another hindrance in the field of kratom research. Exposure to kratom is difficult to monitor given the plant's status among many users as recreational drugs. Achieving a reliable measure of exposure becomes complex as kratom oftentimes is used in conjunction with other substances, particularly classical opioids. Hence, determining the exact linkage between specific clinical effects and kratom exposure remains challenging, thereby slowing down progress in research. Additionally, the potential impact of kratom's complex effects on drug substitution therapies also comes into question as a research hurdle. Therefore, inherent difficulties and complexities embedded within kratom exposure translate into significant obstacles in advancing kratom research.

What roles do different stakeholders play in collaborative kratom research efforts?

Research on the antinociceptive effects and potential for abuse of kratom has engaged multiple stakeholders. In the scientific community, researchers like Smith, Grundmann, and Kruegel AC have significantly contributed to the understanding of kratom's complex phytochemistry, especially focusing on the metabolism of mitragynine, kratom's prominent alkaloid. Their studies explore its potential for pain relief and its intricate interaction with opioid receptors. These research efforts are complemented by clinical studies which delve into the practical applications and limitations of kratom use in treating withdrawal symptoms and chronic pain.

Outside the scientific sphere, other stakeholders also arise as crucial players. Law enforcement agencies, policy makers, and advocate groups are closely monitoring the developments in kratom research. They are particularly interested in findings concerning kratom's potential for abuse, making the insights put forth by researchers like Grundmann O and Boyer incredibly valuable. Moreover, firsthand accounts from a sample of substance users serve as an indispensable resource, offering a ground-level perspective that complements the formal research. Guided by the collective effort of these diverse stakeholders, the course of kratom research is continually being shaped and refined.

Is kratom research influencing drug policy changes?

The comprehensive review of kratom use patterns and the scholarly decoding of its chemocompounds have been instrumental in shaping certain drug policies. Claims of beneficial effects such as a potential opioid analgesic, borne by traditional medicine narratives and user experiences, have buoyed up its popularity as an herbal supplement. Nonetheless, these remain largely anecdotal until substantiated by rigorous clinical trials, thus continuing to place kratom in a gray zone regulated mostly by health advisories rather than outright bans. As herbal medicines increase public appeal, regulatory bodies like the FDA grapple with finding the middle ground between endorsing unproven medicines and countering illicit drug users.

Ongoing research funded by institutions like the National Institute on Drug Abuse has a crucial role. For instance, the evaluation of the substance's opioid-like effects is inclined to provide meaningful insights into its potential medical use. Some argue the use of kratom as an herbal blend to aid withdrawal from opioid drugs, and yet, without scientific consensus, definite policy alterations do not occur overnight. While this may seem to slow the pace of kratom research, the objective remains to ensure the safe integration of nature's bounty into formal medicine discourses.

Is kratom research safety a well-studied area?

The safety of kratom research is indeed an area of interest among scientists and researchers. Studies involving mitragynine in mice have yielded insightful information regarding potential side effects and intoxications with mitragynine. Comprehensive pharmacokinetic studies on kratom use are also being undertaken to understand its interactions with the body over time. Swogger MT and colleagues' study findings stand as solid groundwork in the field, providing crucial details about kratom's safety profile.

However, the difficulty lies in understanding the intricate relationship between kratom use and the use of other illicit substances. Studies by Singh D and Singh et al. have made significant strides in this aspect by demonstrating kratom's potential in reducing dependency on more dangerous narcotics. Researchers like Kruegel have been examining the use of kratom alongside substances like Salvia divinorum. Yet, MMWR Morb reports suggest that more needs to be done in this area to fully unravel the complexities of kratom and how it interacts with other substances in real-world scenarios.

What are the potential benefits of kratom research?

The subject of kratom research holds a promising potential, particularly regarding its potential role in addressing issues of substance dependence. The emergence of fatal intoxications due to the opioid crisis has bolstered the need to explore alternatives like kratom. Several studies revolving around kratom report considerably lesser instances of physical dependence as compared to traditional opioids. This could mark an essential stride towards mitigating the growing issues of opioid abuse.

Furthermore, it is documented that kratom withdrawal appears to have less severe implications than withdrawal from more potent substances. This is of significant interest for those dealing with withdrawal symptoms and battling past-year kratom use. Scientific literature shows that kratom is traditionally associated with combating mental disorders, as well as serving as a throughput assay in the process of identifying pharmacologically active compounds in commercial kratom products. Hence, the further exploration of kratom carries potent benefits in developing a better understanding of its therapeutic and harmful properties.

How is kratom research conducted in humans?

Kratom research in humans is primarily conducted by studying the health effects through user-based data collection models like self-report data surveys and clinical reports. These surveys typically include a wide sample range, from regular users to those experimenting with different strains, dosages, and methods of consumption. Often, the data collection involves anonymous questionnaires to understand the use patterns, health effects, and unwanted side effects from extensive use.

To shine a light on disorder symptoms associated with chronic kratom use, a series of diagnostic tests are often employed in controlled research environments. These tests can help identify if kratom exacerbates or potentially aids different mental and physical conditions. While the self-report data is a subjective mode of information, analysis of clinical reports provides an evidence-based approach to weigh the therapeutic potentials against risks associated with kratom. Despite the hinted benefits, unwarranted consumption could lead to a myriad of potential issues underlining the relevance of ongoing research.
For more information about kratom research contact K Tropix today and we will be happy to help you.

Sources

Chad Hartley, Marilyn Bulloch, Scott R. Penzak. (2021) Clinical Pharmacology of the Dietary Supplement, Kratom (Mitragyna speciosa) Retrieved from: https://www.researchgate.net/publication/356192146

Steven C. Eastlack, Elyse M. Cornett, Alan D. (2020) "Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review" Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203303/

Prozialeck, Walter C., et al. "Pharmacology of Kratom: An Emerging Botanical Agent With Stimulant, Analgesic and Opioid-Like Effects." Retrieved from: https://www.degruyter.com/document/doi/10.7556/jaoa.2012.112.12.792/html

Prat, S. S., Rizvi, S. A., & Chaimowitz, G. A.(2020) "Kratom-induced Psychosis: Case report and literature investigation." Retrieved from: https://mulpress.mcmaster.ca/ijrr/article/view/4134

Philipp, Anika A., et al. (2019) "Pharmacokinetics and pharmacodynamics of mitragynine, the principle alkaloid of Mitragyna speciosa: present knowledge and future directions in perspective of pain." Retrieved from: https://www.degruyter.com/document/doi/10.1515/jbcpp-2019-0138/html

Singh, Darshan, et al. (2020) "Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users." Retrieved from: https://www.sciencedirect.com/science/article/abs/pii/S0376871620302403

Garcia-Romeu, Albert, et al. (2020) "Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic." Retrieved from: https://www.researchgate.net/publication/340748786_Kratom_Mitragyna_speciosa_User_demographics_use_patterns_and_implications_for_the_opioid_epidemic

Swogger, Marc T., et al. (2020) "Kratom use and mental health: A systematic review." Retrieved from: https://www.sciencedirect.com/science/article/abs/pii/S0376871620303663